Biomarker research plays a crucial role in drug discovery, particularly in target identification and candidate drug screening. Biomarker analysis forms an essential part of mechanistic investigation, efficacy evaluation, bioavailability assessment, and safety considerations. The accuracy and sensitivity of measurements are critical when determining whether a study can proceed.
Leveraging advanced analytical technologies, Muridda provides clients with bioanalytical services supporting the safety evaluation of both small‑molecule and large‑molecule drugs.
Service Scope
- LC‑MS/MS biomarker analysis
- Ligand binding biomarker analysis
- Biomarker method development and validation
- Biomarker sample analysis
- Formulation analysis
- Bioanalysis of preclinical and clinical samples
Analyte types cover: Small molecules and macromolecules (including DNA, RNA, and vaccines)